Figure 1

Figure 1. Comparison of the change scores in clinical outcomes in the completers in the two treatment groups. From: Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.

Change in Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety scale (HAM-A), Resilience, Distress and Burden scores are reported as the differences between scores at week 12 and baseline in the placebo (0) and the escitalopram () groups.

H. Lavretsky, et al. Am J Geriatr Psychiatry. ;18(2):154.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk